Collegium Pharmaceutical, Inc. (COLL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/08/25
Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual MeetingGlobeNewsWire • 08/25/25
Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/07/25
Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass EstimatesZacks Investment Research • 08/07/25
Wall Street Analysts See a 33.91% Upside in Collegium Pharmaceutical (COLL): Can the Stock Really Move This High?Zacks Investment Research • 07/25/25
Collegium Pharmaceutical: Stock Deserves A "Buy" Call On Undervaluation Of ADHD DrugSeeking Alpha • 06/30/25
Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key MetricsZacks Investment Research • 05/08/25
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research • 05/08/25
Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company ProgressGlobeNewsWire • 05/08/25
Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 05/01/25
Collegium to Participate in 24th Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/01/25
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual MeetingGlobeNewsWire • 03/27/25
Collegium Announces Updates to its Board of Directors and Executive Leadership TeamGlobeNewsWire • 03/17/25
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health CareGlobeNewsWire • 03/10/25